IX Biopharma Ltd
SGX:42C
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of IX Biopharma Ltd (42C) under the Base Case is SGD per share. Compared with the current market price of 0.475 SGD, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What IX Biopharma Does
IX Biopharma Ltd is a Singapore-based pharmaceutical company that develops and sells drug delivery products and prescription medicines. Its main idea is to make certain drugs easier to take and more consistent to use by putting them into formats such as oral wafers and other fast-dissolving or sublingual delivery forms. It also works on specialty pharmaceutical products that target pain, sleep, and other niche treatment areas.
- Headquarters
- Singapore SG
- IPO date
- Jul 22, 2015
Revenue & Expenses Breakdown
IX Biopharma Ltd
Earnings Waterfall
IX Biopharma Ltd
What is the Intrinsic Value of one 42C stock?
The intrinsic value for IX Biopharma Ltd (42C) under the Base Case is SGD.
Is 42C stock undervalued or overvalued?
Compared with the current market price of 0.475 SGD, the stock appears .